NCT00161239View on ClinicalTrials.gov

LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma

NATerminatedINTERVENTIONAL

Enrollment

64

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

T-Cell Lymphoma

Interventions

DRUG

Doxil, Methotrexate, L-Asparaginase, Prednisone

Trial Locations (1)

08901

Cancer Institute of New Jersey, New Brunswick

Sponsors

Collaborators (1)

Ortho Biotech, Inc.

All Listed Sponsors

collaborator

Ortho Biotech, Inc.

INDUSTRY

lead

University of Medicine and Dentistry of New Jersey

OTHER